A Phase I Study of Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma.
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2011
At a glance
- Drugs Poly ICLC (Primary)
- Indications B cell lymphoma; Chronic lymphocytic leukaemia; Follicular lymphoma; Lymphoid leukaemia; T cell lymphoma
- Focus Adverse reactions
- 19 Jul 2011 Planned end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Jan 2011 Additional lead trial investigator (Delva Deauna-Limayo, MD) identified as reported by ClinicalTrials.gov.